Skip to content
  • Tuesday, 27 October 2026
  • 12:31 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Eli Lilly’s Triple Agonist Achieves 16.8% Weight Loss in Phase 3 Trial for Type 2 Diabetes, Signaling Major Therapeutic Advance
Laboratory Automation & Robotics

Eli Lilly’s Triple Agonist Achieves 16.8% Weight Loss in Phase 3 Trial for Type 2 Diabetes, Signaling Major Therapeutic Advance

Lana Keisha Mar 19, 2026 0

Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…

Read More
Neuroscience & Brain Research

Researchers Identify Cellular Energy Deficits as Key Biological Marker for Early Stage Major Depression

Rifan Muazin Mar 14, 2026 0

In a collaborative breakthrough that may redefine the clinical understanding of psychiatric disorders, researchers from the University of Queensland and…

Read More
Stem Cell & Regenerative Medicine

Michigan State University Researchers Identify Metabolic Molecular Switch in Sperm with Major Implications for Infertility and Male Contraception

rifanmuazin Mar 14, 2026 0

A team of biomedical researchers at Michigan State University (MSU) has announced the identification of a critical molecular "switch" that…

Read More

Posts pagination

1 … 3 4
Lilly’s plans to buy CAR-T firm Kelonia in deal worth up to $7 billion. Can its deal spree avoid Pfizer’s fate?Northwestern University Engineers Develop Printed Artificial Neurons Capable of Direct Interaction with Biological Brain CellsCancer vaccine borrows COVID immune memory to activate T cells against tumors in miceThe Mediterranean Diet May Protect Heart and Brain Health Through Mitochondrial Microproteins
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development7 Advanced Python Design Patterns for Data ScientistsFrom Childhood Wonder to Smithsonian Curator: Gabriela Farfan’s Scientific Journey into the World of MineralsThe Architectural Evolution of Genius: How Ancient DNA Folding Unlocked the Intelligence of Cephalopods
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
7 Advanced Python Design Patterns for Data Scientists
Evan Lee Salim Oct 27, 2026
Environmental & Analytical Chemistry
From Childhood Wonder to Smithsonian Curator: Gabriela Farfan’s Scientific Journey into the World of Minerals
Abdurrohim Arsyad Oct 27, 2026
Molecular & Cell Biology
The Architectural Evolution of Genius: How Ancient DNA Folding Unlocked the Intelligence of Cephalopods
Angie Faith Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ